SCHEMBL6651573

SCHEMBL6651573

Cc1ccc(C(=O)NCCc2ccccn2)c(C)c1C(N)=O

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.49
ALDH1A1 P00352 1/20 0.49
RAB9A P51151 3/20 0.48
NPC1 O15118 3/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
MAPK1 P28482 1/20 0.48
KCNA5 P22460 3/20 0.48
CYP3A4 P08684 1/20 0.47
PTGFR P43088 1/20 0.47
POLB P06746 1/20 0.47
CHRM4 P08173 1/20 0.46
GAA P10253 1/20 0.45
KCNA3 P22001 1/20 0.45
KDM4E B2RXH2 1/20 0.44
TAS1R3 Q7RTX0 1/20 0.44
TAS1R1 Q7RTX1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL164424 0.88 HPGD (0.57) SMN1; SMN2ALDH1A1RAB9ANPC1MEN1
SCHEMBL6647000 0.82 SMN1; SMN2 (0.52) SMN1; SMN2ALDH1A1RAB9ANPC1POLB
SCHEMBL164426 0.79 L3MBTL1 (0.55) SMN1; SMN2ALDH1A1RAB9ANPC1POLB
SCHEMBL4703237 0.76 POLB (0.59) SMN1; SMN2ALDH1A1RAB9ANPC1MEN1
SCHEMBL2755853 0.74 MAPK1 (0.60) SMN1; SMN2ALDH1A1RAB9ANPC1MEN1
SCHEMBL30206599 0.74 MAPK1 (0.60) SMN1; SMN2ALDH1A1RAB9ANPC1MEN1
SCHEMBL4242979 0.74 KCNA5 (0.54) SMN1; SMN2ALDH1A1RAB9ANPC1MEN1
SCHEMBL166870 0.72 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1RAB9ANPC1POLB
SCHEMBL13947349 0.72 RAB9A (0.65) SMN1; SMN2ALDH1A1RAB9ANPC1MEN1
SCHEMBL1694984 0.72 RAB9A (0.62) SMN1; SMN2ALDH1A1RAB9ANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1453789-A2 N,N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES Elan Pharmaceuticals, Inc. (US) 2004-09-08 EP claimed
WO-2003040096-A2 N, N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES ELAN PHARMACEUTICALS, INC. (US) 2003-05-15 WO claimed